Insider Buying and Selling - NRIX

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
08/04/2026 10b5-1	08/05/2026	Hansen Gwenn Chief Scientific Officer Officer	Sell	-4,111 @ $24.36	($100,141.56)	117,227	(-3.39%)	Direct
08/04/2026 10b5-1	08/04/2026	Van Houte Hans Chief Financial Officer CFO	Sell	-4,761 @ $24.36	($115,989.47)	40,166	(-10.60%)	Direct
06/25/2026 10b5-1	06/25/2026	Hansen Gwenn Chief Scientific Officer Officer	Sell	-5,394 @ $20.00	($107,880.00)	115,005	(-4.48%)	Direct
05/05/2026 10b5-1	05/05/2026	Van Houte Hans Chief Financial Officer CFO	Sell	-14,055 @ $16.60	($233,318.97)	37,592	(-27.21%)	Direct
05/04/2026 10b5-1	05/04/2026	Ring Christine Chief Legal Officer Officer	Sell	-8,148 @ $16.96	($138,209.64)	18,305	(-30.80%)	Direct
05/01/2026 10b5-1	05/01/2026	Ring Christine Chief Legal Officer Officer	Sell	-5,394 @ $16.76	($90,406.68)	26,453	(-16.94%)	Direct
04/02/2026 10b5-1	04/02/2026	Ring Christine Chief Legal Officer Officer	Sell	-8,148 @ $15.24	($124,148.63)	26,453	(-23.55%)	Direct
03/02/2026 10b5-1	03/02/2026	Ring Christine Chief Legal Officer Officer	Sell	-8,148 @ $15.44	($125,792.90)	34,601	(-19.06%)	Direct
02/09/2026 10b5-1	02/09/2026	Ring Christine Chief Legal Officer Officer	Sell	-14,261 @ $16.66	($237,618.21)	42,749	(-25.01%)	Direct
11/03/2025 10b5-1	11/03/2025	Van Houte Hans Chief Financial Officer CFO	Sell	-6,284 @ $12.56	($78,931.44)	37,592	(-14.32%)	Direct

Nurix Therapeutics, Inc. - NRIX